Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milton T Smith

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Surgery|October 14, 2022
Predicting endocrine function after total pancreatectomy and islet cell autotransplantation: A novel approach utilizing computed tomography texture analysisKevin M Turner, Shaun A Wahab, Aaron M Delman, et al.
Surgery|January 17, 2022
Radiation therapy in borderline resectable pancreatic cancer: A reviewKevin M Turner, Aaron M Delman, Jordan R Kharofa, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 10, 2014
Total pancreatectomy with islet cell autotransplantation as the initial treatment for minimal-change chronic pancreatitisGregory C Wilson, Jeffrey M Sutton, Milton T Smith, et al.
Surgery|October 1, 2013
Surgical outcomes after total pancreatectomy and islet cell autotransplantation in pediatric patientsGregory C Wilson, Jeffrey M Sutton, Marzieh Salehi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 4, 2022
Total pancreatectomy and islet cell autotransplantation: a 10-year update on outcomes and assessment of long-term durabilityKevin M Turner, Aaron M Delman, Eileen C Donovan, et al.
Annals of Surgical Oncology|March 31, 2022
Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma?Kevin M Turner, Aaron M Delman, Allison M Ammann, et al.
Annals of Surgical Oncology|February 10, 2022
Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough?Kevin M Turner, Aaron M Delman, Dennis M Vaysburg, et al.
Surgery|September 21, 2014
High readmission rates after surgery for chronic pancreatitisAlexander V Fisher, Jeffrey M Sutton, Gregory C Wilson, et al.
Surgery|July 25, 2016
The natural history of chronic pancreatitis after operative intervention: The need for revisional operationVikrom K Dhar, Nick C Levinsky, Brent T Xia, et al.
Surgery|July 16, 2015
Completion pancreatectomy and islet cell autotransplantation as salvage therapy for patients failing previous operative interventions for chronic pancreatitisGregory C Wilson, Jeffrey M Sutton, Milton T Smith, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Surgery|October 14, 2022
Predicting endocrine function after total pancreatectomy and islet cell autotransplantation: A novel approach utilizing computed tomography texture analysisKevin M Turner, Shaun A Wahab, Aaron M Delman, et al.
Surgery|January 17, 2022
Radiation therapy in borderline resectable pancreatic cancer: A reviewKevin M Turner, Aaron M Delman, Jordan R Kharofa, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 10, 2014
Total pancreatectomy with islet cell autotransplantation as the initial treatment for minimal-change chronic pancreatitisGregory C Wilson, Jeffrey M Sutton, Milton T Smith, et al.
Surgery|October 1, 2013
Surgical outcomes after total pancreatectomy and islet cell autotransplantation in pediatric patientsGregory C Wilson, Jeffrey M Sutton, Marzieh Salehi, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 4, 2022
Total pancreatectomy and islet cell autotransplantation: a 10-year update on outcomes and assessment of long-term durabilityKevin M Turner, Aaron M Delman, Eileen C Donovan, et al.
Annals of Surgical Oncology|March 31, 2022
Is There a Benefit to Adjuvant Chemotherapy in Resected, Early Stage Pancreatic Ductal Adenocarcinoma?Kevin M Turner, Aaron M Delman, Allison M Ammann, et al.
Annals of Surgical Oncology|February 10, 2022
Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough?Kevin M Turner, Aaron M Delman, Dennis M Vaysburg, et al.
Surgery|September 21, 2014
High readmission rates after surgery for chronic pancreatitisAlexander V Fisher, Jeffrey M Sutton, Gregory C Wilson, et al.
Surgery|July 25, 2016
The natural history of chronic pancreatitis after operative intervention: The need for revisional operationVikrom K Dhar, Nick C Levinsky, Brent T Xia, et al.
Surgery|July 16, 2015
Completion pancreatectomy and islet cell autotransplantation as salvage therapy for patients failing previous operative interventions for chronic pancreatitisGregory C Wilson, Jeffrey M Sutton, Milton T Smith, et al.
Pageof 3